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Context: Heart Rate Variability (HRV) indicates how heart rate changes in response to
inner and external stimuli. HRV is linked to health status and it is an indirect marker of
the autonomic nervous system (ANS) function.
Objective: To investigate the influence of osteopathic manipulative treatment (OMT) on
cardiac autonomic modulation in healthy subjects, compared with sham therapy and
control group.
Methods: Sixty-six healthy subjects, both male and female, were included in the present
3-armed randomized placebo controlled within subject cross-over single blinded study.
Participants were asymptomatic adults (26.7 ± 8.4 y, 51% male, BMI 18.5 ± 4.8),
both smokers and non-smokers and not on medications. At enrollment subjects were
randomized in three groups: A, B, C. Standardized structural evaluation followed by a
patient need-based osteopathic treatment was performed in the first session of group A
and in the second session of group B. Standardized evaluation followed by a protocoled
sham treatment was provided in the second session of group A and in the first session
of group B. No intervention was performed in the two sessions of group C, acting as a
time-control. The trial was registered on clinicaltrials.gov identifier: NCT01908920.
Main Outcomes Measures: HRV was calculated from electrocardiography before,
during and after the intervention, for a total amount time of 25min and considering
frequency domain as well as linear and non-linear methods as outcome measures.
Results: OMT engendered a statistically significant increase of parasympathetic activity,
as shown by High Frequency power (p < 0.001), expressed in normalized and absolute
unit, and possibly decrease of sympathetic activity, as revealed by Low Frequency power
(p < 0.01); results also showed a reduction of Low Frequency/High Frequency ratio
(p < 0.001) and Detrended fluctuation scaling exponent (p < 0.05).
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Conclusions: Findings suggested that OMT can influence ANS activity increasing
parasympathetic function and decreasing sympathetic activity, compared to sham
therapy and control group.
Keywords: osteopathic medicine, heart rate variability, high frequency, healthy subjects, smoking, autonomic
nervous system, parasympathetic effect
Introduction
Heart rate, one of the most variable organism’s phenomena,
corresponds to a number of heart beats per minute. Heart
rate variability (HRV) is the variation of the consecutive RR
interval period (Aa.Vv., 1996; Kara et al., 2003; Freeman et al.,
2006), where R is a point corresponding to the QRS complex
peak of the electrocardiogram wave, related to left ventricle
depolarization. Its variability, depending on metabolic (inner)
and environmental (external) stimuli (Caruana-Montaldo et al.,
2000; Henley et al., 2008; Routledge et al., 2010), is responsible
of maintaining homeostasis. HRV can be influenced by several
factors, such as intrinsic variability of sinoatrial node (Ponard
et al., 2007), neurohormonal hematic fluctuation (Galetta et al.,
2008), circadian rhythm (Huikuri et al., 1990; Bonnemeier et al.,
2003; Cavallari et al., 2010), and autonomic nervous system
(ANS) activity.
HRV is considered an indirect proxy of ANS function
(Aa.Vv., 1996; Porta et al., 2001; Malliani and Montano, 2002;
Pumprla et al., 2002; Freeman et al., 2006; Kemp et al., 2012),
as parasympathetic and sympathetic activity regulates cardiac
rate and inotropism. These branches respectively lead to a
reduced or increased efficiency of the cardiovascular pump,
modifying, therefore, HRV parameters (Aubert et al., 2003;
Guyton and Hall, 2006). To quantify the sympathetic and
parasympathetic activities, several HRV indices and methods are
used. The most common are the frequency domain indices—low
frequency (LF) and high frequency (HF)—and the ratio between
LF/HF.
Among the external factors able to influence HRV-values,
smoking has been demonstrated to be particularly strong
(Minami et al., 1999; Pope et al., 2001). A study conducted in
1999 byMinami et al. investigated the effect of smoking cessation
on HRV and other cardiovascular indices (Minami et al., 1999).
Results showed that smoking cessation significantly decreased
the high frequency (HF) component throughout a 24-h period,
indicating that in habitual smokers, parasympathetic nervous
system is altered. HRV parameters have been linked, also, to
health status (Karemaker and Lie, 2000).
In addition to traditional medicine, also complementary and
alternative medicines (CAM) have been starting to use HRV
variations to understand how different therapeutic approaches,
like homeopathy (Mishra et al., 2011), massage (Lee et al., 2011),
acupuncture (Haker et al., 2000; Li et al., 2003; Litscher, 2009,
2010; Arai et al., 2011; Anderson et al., 2012; Huang et al., 2012;
Litscher et al., 2012), auricular acupuncture (Gao et al., 2012) can
influence health status.
Among CAM, osteopathic medicine is a form of drug-free
non-invasive manual medicine. It relies on manual contact
for diagnosis and treatment. Osteopaths use a wide variety
of tests to locate the somatic dysfunction (SD) (ICD-101CM
Diagnosis Code M99.09-09). Diagnostic criteria are focused on
tissue abnormality and tone. Areas of asymmetry, misalignment
of bony landmarks and the quality of motion are evaluated.
Osteopathic care is based on two phases: structural evaluation
and treatment. The structural evaluation aims to locate SDs using
a well-established sequence of structural tests. The treatment
currently encompasses more than 20 types of manual techniques
and has the scope to treat SDs.
In osteopathy, Henley’s work (Henley et al., 2008) examined
HRV changes in healthy subjects receiving osteopathic
manipulative treatment (OMT) compared to control and
sham therapy groups after tilt test. Low frequency expressed in
normalized unit (nuLF) significantly increased in the control
and sham groups compared to OMT group when subjects
move from horizontal to head-up tilt. After the application of
OMT, nuLF increased significantly less in the head-up position
than in control and sham groups. Contextually high frequency,
measured in normalized units, (nuHF) was significantly lower
in OMT group compared to sham and control. Moreover, OMT
group occurred to have a lower LF/HF ratio in the head-up
tilt phase after intervention compared to sham and control
groups.
In 2013, another osteopathic study (Giles et al., 2013)
investigated the effect of sub-occipital decompression (a specific
cranium-sacral technique) on HRV indices in healthy subjects,
showing an increase of absolute HF and a decrease of LF/HF
ratio, compared to sham therapy and control groups. However,
several limitations could be pointed out leading to lack of clinical
generalizability of findings. Firstly, both research focused on
a single session without investigating the long term variations
of HRV parameters. Secondly, smokers were not included in
Henley’s study, while in Giles’ one no information was provided
about smoking. Finally a single standard, pre-determined
technique was administered in both studies not considering usual
clinical care procedures. The present trial, therefore, aimed to
investigate the effect of OMT on ANS using HRV as a primary
outcome measure.
Materials and Methods
Primary outcome of this randomized placebo controlled within
subject cross-over single blinded study was to explore the extent
to which OMT changed nuHF-value, compared to sham therapy
and control group. Secondary outcomes were baseline changes
in auLF, LF/HF ratio and Detrended fluctuation scaling exponent
(DFAα1), HF absolute power (auHF measured in absolute units;
i.e., ms2).
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Population
Asymptomatic healthy adults, of either gender, were considered
eligible for the study. Inclusion criteria applied were: age
between 18 and 45 years; absence of chronic pain or acute
symptomatology during the last 72 h before the session; no
diagnosed pathology.
Exclusion criteria were: pregnancy; menopause; menstrual
flow during the session; alcoholism; alcohol abuse 48 h prior to
the session; chronic pain; diagnosis of pathological condition;
chronic drug treatment; use of medications and drugs during the
last 72 h; use of orthotic devices during the last 3 months; medical
history of surgical interventions; last OMT at least 3 months
before the session.
Volunteers from different universities were recruited from
May 01, 2013 to July 31, 2013 through e-mail, phone, direct
contact and leaflet/posters. The latter were posted at Accademia
Italiana Osteopatia Tradizionale (AIOT) and at an osteopathic
clinical center inviting people to call a phone number managed
by the recruitment supervisor.
Informed consent was read and signed by each volunteer at
the beginning of the first session. The trial was approved by the
institutional review board of AIOT. The trial was registered on
clinicaltrials.gov identifier: NCT01908920.
Experimental Protocol
Subjects were divided and randomized into three groups using
“permuted block” randomization method (block size equal
to 3), formulated by the statistical software R v.2.15.1 (R
Developmental Core Team, 2010) and stratified by smoking. A
ternary sequence (0, 1, 2) was used to allocate subjects into groups
A–C (Figure 1).
First session could be rescheduled if the subject presented at
least one of the following exclusion criteria: acute pain in the
last 72 h, assumption of any medicine or drug in the 72 h before
the session, menstrual flow during the intervention day, alcohol
abuse in the last 48 h. Subjects were considered drop-out in case
of nonattendance at the second session.
Subjects allocated to treatment groups A and B received both
an OMT and a sham therapy session at different time points on
the basis of the cross-over design. At the first session group A
received OMT while group B received sham treatment. At the
second session group A received sham treatment whilst group B
received OMT. Group C was used as time control thus neither
treatment nor sham therapy were provided in both two sessions
(Figure 1).
Evaluations and treatments were performed in the same room,
with stable temperature and humidity, to avoid any influence on
ANS activity. Moreover, the 2 weekly sessions were scheduled at
the same hour to control for circadian rhythm.
The OMT intervention consisted in a patient’s need based
treatment, thus no pre-determined protocol was applied.
Osteopathic session lasted 25min, 10min for evaluation and
15min for treatment. Techniques used in the present study were
left at the discretion of the operator but limited to balance
ligamentous techniques, balance membranous techniques and
cranio-sacral techniques (Magoun, 1976).
For this trial, sham therapy mimicked the osteopathic care,
based, therefore, on structural evaluation and treatment. The
sham evaluation overlapped the osteopathic structural evaluation
procedure in terms of tests and time. The sham treatment
consisted in contacting an established sequence of anatomical
areas for 2min each: right ankle, left knee, right hip, diaphragm,
right shoulder, neck, cranium. The operator mentally counted
from 120 to 0 for each area to prevent placebo autonomic
activation (Meissner, 2011). Sham session lasted 25, 10min for
evaluation and 15min for treatment.
All interventions were performed by four osteopaths with the
same educational curricula assigned randomly to group A or
B. Each osteopath was responsible for the same patient from
enrollment to the end of the study.
Control group sessions were managed by one operator in
charge of data collection, no osteopaths were present.
Osteopaths were blinded to the study design, outcome
and HRV data. Two external operators were in charge of
randomization and data collection. Both were blinded to the
study design and outcome, as well as allocation. All data collected
was examined by an external statistician, who was blinded
of randomization, allocation and study design. Subjects were
blinded to study design, outcome and the type of intervention
received.
Data Analyses
Data was collected through a socio-demographic form and
a HRV detector system Flexcomp (http://www.righetto.biz/
Biofeedback/flexcomp_infiniti.htm). The latter is composed of
a plethysmograph put on the third finger of the left hand,
two cutaneous conductance detectors on the second and fourth
left fingers and two stripes positioned around the thorax and
the abdomen to control lung ventilation. R–R intervals were
extracted from ECG (256Hz sample rate) using Physiology Suit
software (www.thoughttechnology.com/physsuite) and imported
in Kubios software (http://kubios.uef.fi) to calculate all HRV
parameters considered in the present trial. RR series of 300
cardiac beats were analyzed. Only one sequence was analyzed
in each condition. If more than 300 RR-values were recorded, a
sequence of 300 beats was selected randomly inside the period of
analysis. If less than 300 RR-values were recorded, all the values
were analyzed.
HRV analysis method, based on processing recorded RR
intervals, was divided into linear analysis (time and frequency
domain) and nonlinear analysis (Aubert et al., 2003). From power
spectra (Fast Fourier transformation using Blackman Harris
window) of equidistant linear interpolated (4Hz) tachograms
(resampled to 2Hz) the following frequency domain standard
HRV indices were considered for linear analysis: absolute HF
and nuHF, from 0.15 to 0.4Hz, is a signal of parasympathetic
modulation on heart rate (Aa.Vv., 1996; Berntson et al., 1997;
Taylor et al., 1998); absolute LF and nuLF component, from 0.04
to 0.15Hz bandy (Lane et al., 2009). LF/HF ratio is showed
to be a reliable marker of ANS balance (Pagani et al., 1986;
Malliani et al., 1991). DFAα1 was considered for nonlinear
analysis. DFAα1 is a proxy of the parasympathetic function,
it is considered more sensitive (Kemp et al., 2010, 2012) and
able to catch the long term correlations and complexity in RR
interval series (Peng et al., 1993). The DFA method detected
long-range correlations between inter-beat intervals separated by
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FIGURE 1 | Flow-chart of the study.
several beats by investigating the scaling behavior of the heartbeat
fluctuations on different time scales. A detailed description of
the DFA algorithm and its underlying theory for the analysis
of neuronal oscillations was pertinently presented by Hardstone
et al. (2012). A fractal structure of heart rate was quantified by
estimating a short-term (a1, short-term fluctuations, obtained
from the range 4 ≤ n ≤ 16) and a long-term (a2, long-term
fluctuations, obtained from the range 16 ≤ n ≤ 64) scaling
exponent by DFA.
At enrollment, subjects completed the socio-demographic
form. For each session, a paradigm was developed consisting of
4 conditions: (1) 5min no hands-on for baseline assessment; (2)
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10min for either osteopathic or sham evaluation; (3) 15min for
the treatment, hands-on subjects; and (4) 5 final min where no
hands contact was provided.
HRV records were performed at (1), (3), and (4).
Subjects were instructed to keep still, eyes closed and in silence
during the three recording steps.
Statistical Analysis
Sample size was computed considering a correlation coefficient
among repeated measure of 0.15, an effect size of 0.3, a type-one
error of 0.05 and a power of 0.80. The final sample n = 51 (17
per group) was additionally increased up to 60 to prevent loss of
power.
A per protocol analysis was performed in the present trial.
Stationary was assessed using the RWS test (Porta et al.,
2004), which checks if mean and variance remain constant
over M patterns. Giving a series of RR, the first step was
to use Kolmogorov Smirnov goodness-of-fit test to evaluate
the normality of the distribution (p < 0.05). If non-normal
distribution resulted, a log transformation was applied and
normality retested. If data was still non-normally distributed,
then it was finally rejected. The next step was to test normality
along M patterns, which are randomly selected from a set of
sequences of length L (Porta et al., 2004). To test the stability of
the mean an ANOVA was performed, otherwise Kruskal–Wallis
test. To test the stability of the variance, Barlett test was used if
data was normally distributed otherwise Levene’s test using the
median was adopted.
A descriptive analysis of the population was performed at the
baseline using arithmetic means, medians, standard deviations
and standard errors. Univariate statistical tests used chi square
test for establishing differences among categorical variables,
such as gender, OMT, and smoking. Results were expressed in
percentage.
At baseline, One-Way ANOVA was used to analyze
continuous variables, such as age, BMI, nuHF, auHF, nuLF, auLF,
LF/HF ratio, and DFAα1. Tukey post-hoc analysis was used to
explore any statistical difference resulted from ANOVA.
Mixed effect regression (MER) model considering random
effect for osteopath and a fixed effect for period was used to
determine dependent variables differences between groups. Post-
hoc pairwise analysis adjusted by Holm-Bonferroni correction
was used to explore any statistical difference resulted from MER.
Sensitivity analyses were performed according to smoking and
session.
Effect size was computed using Cohen’s d to show any clinical
effect of OMT compared to sham therapy and control group.
Statistical significance was based on a probability level at less than
0.05. All analyses were performed using R v 2.15.01.
Results
Out of 97 volunteers, 66 were included in the study and
randomized. Nine subjects dropped out and consequently 57
completed the study (Figure 1). None of the subject enrolled
recorded less than 300 cardiac cycles at any study condition.
TABLE 1 | Baseline values of osteopathic manipulative treatment (OMT),
Sham, and Control groups.
OMT Sham Control F p adj
Age* 26.5 ± 8.8 28 ± 8.1 25.6 ± 8.2 0.46 0.63
BMI* 18.9 ± 8.8 18.7 ± 2.4 18.0 ± 3.3 0.46 0.63
Male$ 10 (53) 14(74) 10 (53) – 0.31
Previous OMT$ 5 (26) 8 (42) 8 (42) – 0.5
Smoking$ 7 (37) 6 (32) 7 (37) – 0.93
auHF* 1391 ± 1850 1138 ± 650 944 ± 1563 0.92 0.40
nuHF* 47.12 ± 26.36 50.85 ± 17.4 46.8 ± 18.5 0.34 0.71
auLF 1138 ± 676 1481 ± 2098 1290 ± 1705 0.89 0.48
nuLF* 54.34 ± 26.37 48.99 ± 17.41 53.14 ± 18.52 0.61 0.55
DFAa1* 1.05 ± 0.33 0.91 ± 0.19 0.96 ± 0.26 0.55 0.58
LF/HF* 2.34 ± 2.6 1.28 ± 1.09 1.87 ± 2.41 0.47 0.63
Numbers in table are: *mean ± sd, $n (%). p-values from *ANOVA and $chi square test.
The RWS revealed a stationarity of mean and variance. At
enrollment, One-Way ANOVA did not reveal any statistically
significant imbalance among OMT, sham and control, in terms
of age, BMI, gender, previous OMT experience, smoking,
nuHF, auHF, nuLF, auLF, DFAα1, and LF/HF ratio values
(Table 1). Among the 38 participants receiving sham and OMT
interventions, the percentage of subjects able to correctly guess
which treatment they received did not differ (session 1: 16%OMT
vs. 21% Sham, p = 0.68; session 2: 31% OMT vs. 26% Sham,
p = 0.72).
Primary Outcome
MER showed a statistically significant difference between groups
on the primary outcome nuHF (p < 0.001) (Figure 2B). Tukey
post-hoc analysis revealed that OMT group significantly increased
nuHF-values compared to sham (p < 0.01) and control group
(p < 0.001). Sham therapy did not show any significant
modification of nuHF-values compared to control group (p =
0.44). OMT had a medium effect size compared to sham therapy
(d = 0.38) and control group (d = 0.49).
Secondary Outcome
Low Frequency
auLF analysis showed a statistically relevant difference between
groups (p < 0.01) (Figure 2D). Tukey analysis demonstrated
that OMT significantly decreased auLF-values compared to sham
(p < 0.05) and control (p < 0.001). No similar results were
shown for sham and control (p = 0.40).
Detrended Fluctuation Scaling Exponent (DFAα1)
DFAα1 was statistically different between groups (p < 0.05)
(Figure 2C). Post-hoc analysis showed that OMT significantly
decreases DFAα1-values compared to control (p < 0.001) but
it was almost significant compared to sham therapy (p = 0.09).
Moreover, sham therapy significantly lowered DFAα1 compared
to control group (p = 0.05). Effect sizes were small (OMT vs.
sham group: d = 0.22) and medium (OMT vs. control: d = 0.51;
sham vs. control: d = 0.30).
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FIGURE 2 | Heart rate variability (HRV) findings for: high
frequency (HF) absolute units (au, A) and normalized units
(nu, B); detrended fluctuation scaling exponent (DFAα1, C);
low frequency (LF, D); low frequency/high frequency ratio
(LF/HF, E). Data presented are means ± standard errors of the
mean (SEM). *statistically significant differences (p < 0.001) in OMT
group compared to sham and control groups. # statistically
significant decrease of DFAα1 (p < 0.05) in sham group compared
to control. C, control; O, osteopathic manipulative treatment; S,
sham therapy.
Low Frequency/High Frequency Ratio
Statistically significant decrease of LF/HF ratio was
observed between groups (p < 0.001) (Figure 2E). Tukey
post-hoc analysis showed that OMT scored significantly
better than sham therapy (p < 0.001) and control
(p < 0.001).
Sham therapy did not show any statistical association
compared to control group (p = 0.40).
High Frequency—Absolute Unit
auHF showed statistically significant differences between groups
(p < 0.01) (Figure 2A). Post-hoc analysis demonstrated that in
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FIGURE 3 | Sensitivity analysis stratified by smoking. Numbers are
mean ± SEM. HF(au) (A), high frequency absolute units; HF(nu) (B), high
frequency normalized unit; DFAα1 (C), detrended fluctuation scaling
exponent; LF (D), low frequency; LF/HF (E), low frequency/high frequency
ratio. Each figure shows HRV data recorded during the three steps of the
each session: baseline (5min), treatment (15min), end (5min). *p < 0.001
from regression mixed effect model. LF and LF/HF ratio showed a relevant
increase in OMT group between end and treatment periods.
the OMT group a significant increase was revealed compared to
sham and control (p < 0.001).
Sensitivity Analysis
Sensitivity analyses were performed taking into account smoking
and sessions.
Stratifying by smoking, results showed statistically
significance baseline differences in the OMT group for
nuHF, LF/HF ratio, auHF and DFAα1 both in smokers and
non-smokers as showed in Figures 3, 4. In more details, OMT
significantly changed baseline values in all HRV parameters
measured (p < 0.01). Sham therapy and time control groups did
not demonstrate any valuable change.
The first and second sessions of OMT led to an increase
of nuHF and auHF as well as a decrease of auLF, LF/HF
ratio, and DFAα1 compared to baseline values (Figures 5, 6,
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FIGURE 4 | Sensitivity analysis stratified by non-smoking.
Numbers are mean ± SEM. HF(au) (A), high frequency absolute
units; HF(nu) (B), high frequency normalized unit; DFAα1 (C),
detrended fluctuation scaling exponent; LF (D), low frequency; LF/HF
(E), low frequency/high frequency ratio. Each figure shows HRV
data recorded during the three steps of the each session: baseline
(5min), treatment (15min), end (5min). *p < 0.001 from regression
mixed effect model.
statistically significant at p < 0.01). Sham therapy and time
control group did not reveal variations compared to baseline
values.
Adverse Events
No adverse events were reported during the trial.
Discussion
The present trial showed that OMT modifies ANS activity
through modulating the parasympathetic functioning of healthy
subjects compared to sham therapy and control groups.
Statistically significant changes were revealed during the
Frontiers in Neuroscience | www.frontiersin.org 8 August 2015 | Volume 9 | Article 272
Ruffini et al. HRV parameters variations following OMT
FIGURE 5 | Sensitivity analysis stratified by session 1. Numbers
are mean ± SEM. HF(au) (A), high frequency absolute units; HF(nu)
(B), high frequency normalized unit; DFAα1 (C), detrended
fluctuation scaling exponent; LF (D), low frequency; LF/HF (E), low
frequency/high frequency ratio. Each figure shows HRV data
recorded during the three steps of the each session: baseline
(5min), treatment (15min), end (5min). *p < 0.001 from regression
mixed effect model.
treatment period. This clinical study used a larger sample
size to confirm previous findings showing that OMT can
globally influence the tonic activity of ANS (Henley et al.,
2008; Giles et al., 2013). However, several differences can be
highlighted between former studies and this trial. Henley used
an additional tilt test to evaluate HRV variations in response to
an environmental stress. Then, both Henley and Giles limited
the OMT intervention to anatomical areas (cervical spine and
sub-occipital area) directly connected with parasympathetic and
sympathetic heart rate control. The present trial used a patients’
need-based treatment to improve the clinical generalizability of
findings.
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FIGURE 6 | Sensitivity analysis stratified by session 2. Numbers are
mean ± SEM. HF(au) (A), high frequency absolute units; HF(nu) (B), high
frequency normalized unit; DFAα1 (C), detrended fluctuation scaling
exponent; LF (D), low frequency; LF/HF (E), low frequency/high frequency
ratio. Each figure shows HRV data recorded during the three steps of the
each session: baseline (5min), treatment (15min), end (5min). *p < 0.001
from regression mixed effect model. Significant differences between baseline
and end periods are shown only for HF and LF/HF-values.
Interestingly, thereweretrenddifferencesbetweensmokersand
non-smokers forHRV-values in theOMTgroup. In non-smokers,
HRV-values of the final 5min record remained unchanged
compared to the HRV-values of the treatment phase. In contrast,
smokerspresentedadifference, althoughnot statistical significant,
of the HRV-values between the final 5min and the treatment
phase, showing an influence of smoking on HRV changes after
OMT. Overall, we suggest that the treatment of an osteopathic
dysfunction, independently from its location, could modify
autonomic activity of both smokers and non-smokers.
Interestingly, other OMT mediated improvements in clinical
outcomes such as reduction of pain grade and frequency and
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improvement of the range of motion, may correlate to the
decrease of sympathetic activity resulting from this study. As
a matter of fact, parasympathetic branch of ANS has anti-
inflammatory and anti-nociceptive actions. Tracey demonstrated
that the release of acetylcholine by vagal endings binds to alpha-
7 nicotinic receptors of macrophages selectively inhibiting pro-
inflammatory cytokines production (Tracey, 2002). Sympathetic
branch has instead an opposite pro-inflammatory action,
potentially increasing pain grade. A 2013 study showed how
interleukin-6 release, induced by norepinephrine, is mediated
by β2-adrenergic receptors (Stohl et al., 2013). Clinical effects
following osteopathic treatment could also be referred to
the trophotropic tuning of the patient’s organism, due to
the shift of ANS tonic activity toward the parasympathetic
functioning. According to Hess (1955), the trophotropic tuning
is characterized by a decrease in frequency and an increase in
amplitude of brain waves, a decrease in heart and respiratory rate,
an increase in skin temperature, a decrease in muscle tension and
anxiety.
Several strengths and limitations have to be considered for
the present trial. No changes to methods and outcomes were
applied after trial commencement. It was based on rigorous
methodology, controlling for allocation, detection, sequence
generation biases. Attention was paid to confounding factors
like temperature, humidity of the room, smoking, and circadian
rhythms. It included a large sample size and a patients’ need-
based treatment. Moreover, DFAα1 was taken into account
as nonlinear parameter to further explore the ANS activity.
Limitations are in terms of incomplete emptiness of the bladder
that was not systematically asked to participants, difficulty to
control for subjects emotional conditions and daily habits before
the trial started.
Conclusion
Results demonstrated that OMT produced changes of tonic
activity of ANS as shown by HF, DFAα1, auLF, and LF/HF ratio
variations. The present study focused on healthy subjects. Future
studies are warranted to further explore the extent to which
OMT can change ANS activity in pathological conditions and
comparing its effect with usual care, hypothesizing that OMT
could be used as a supportive care in addition to traditional
methods.
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